Starting from these data, we decided to evaluate the ability of Gly to act as an EDC by activating the estrogen receptor pathway on PNT1A human prostate cells, a non-tumor cellular system consisting of both estrogen receptors ERα and ERβ [34,35]. Here, ESR2 is linked to neoplasm.